{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-24-110429","form_type":"8-K","ticker":"INM","cik":"0001728328","company_name":"InMed Pharmaceuticals Inc.","filed_at":"2024-12-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.384107+00:00","generated_at":"2026-05-29T01:43:25.140221+00:00","sec_items":["5.07","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"InMed director Janet Grove fails re-election; resignation tendered per majority voting policy","bullets":["Janet Grove received only 44.26% votes for (55.74% withheld); per policy she tendered resignation to Board chair.","Nominating & Governance Committee will review whether to accept Grove's resignation; update to follow.","Four other director nominees re-elected with >96% votes for each (Adams, Hull, Lemerond, Baldasare).","Shareholders approved appointment of Marcum LLP (now CBIZ LLP) as independent auditor for the next year."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-24-110429","json":"https://secwatch.observer/filing/0001213900-24-110429.json","markdown":"https://secwatch.observer/filing/0001213900-24-110429.md","text":"https://secwatch.observer/filing/0001213900-24-110429.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1728328/000121390024110429/0001213900-24-110429-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1728328/000121390024110429/ea0225311-8k_inmed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T01:43:25.140221+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}